Purpose
To standardize evaluation of novel HPV genetic tests globally and thereby ensure quality of assays over time and inter-lab comparability of results. This will support HPV effectiveness assessments globally and improve assay reliability.
Grantee
Division
Global Health
Date
OCTOBER 2024
Region served
GLOBAL
Committed amount
$1,211,723
Grant topic
Vaccine Development
Duration (months)
36
Grantee location
Huddinge, Stockholm, Sweden
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.